Detalles de la búsqueda
1.
Safety and immunogenicity of a 4-component GMMA-based Shigella vaccine in healthy European adults: Stage 1 of a randomized, controlled phase I/II clinical trial.
J Infect Dis
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38853614
2.
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model.
Clin Infect Dis
; 64(8): 1066-1073, 2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28158395
3.
Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenes.
Drugs R D
; 24(1): 1-12, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494581
4.
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine.
NPJ Vaccines
; 9(1): 56, 2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459072
5.
Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.
Front Immunol
; 15: 1340425, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361949
6.
A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development.
Hum Vaccin Immunother
; 18(6): 2136451, 2022 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495000
7.
The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia.
Drugs R D
; 22(1): 1-8, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921644
8.
GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.
Infect Dis Ther
; 11(2): 757-770, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35118580
9.
Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.
Front Immunol
; 13: 971866, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203568
10.
Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension.
Front Immunol
; 12: 671325, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34017343
11.
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.
EClinicalMedicine
; 39: 101076, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430837
12.
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial.
Front Immunol
; 10: 335, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30906291
13.
Safety and immunogenicity of an MF59-adjuvanted subunit influenza vaccine in elderly Chinese subjects.
Immun Ageing
; 5: 2, 2008 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18289372
14.
Education in Vaccinology: An Important Tool for Strengthening Global Health.
Front Immunol
; 9: 1134, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29881385
15.
Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia.
Drugs R D
; 22(3): 253, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35994226
16.
Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.
Infect Dis Ther
; 11(3): 1313, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35435576
17.
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.
Front Immunol
; 8: 1884, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29375556
18.
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.
EBioMedicine
; 22: 164-172, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28735965
19.
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.
PLoS One
; 11(8): e0157385, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27490698
20.
The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants.
Vaccine
; 34(6): 783-90, 2016 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26742945